Jinxin Fertility (1951.HK) traded up 2.71 % during a 24 hours period ending at 01:13 PM Central Europe on Tuesday 27th. One Jinxin Fertility stock can currently be bought for about HKD 2.24 on popular exchanges. Current supply of Jinxin Fertility stocks is 2.7 bn. Jinxin Fertility has a current market capitalization of HKD 6 bn and approximately HKD 23.6 mn worth of Jinxin Fertility was traded on exchanges in the last 24 hours. Since last month end, Jinxin Fertility has traded 8.33 % up. Simple moving average of last 200 days is at HKD 2.29. The highest price of past 52 weeks was recorded at HKD 2.67 on 01/19/2026. 52 weeks low was at HKD 1.92 on 06/30/2026.

Here is how related stocks have performed in the past 24 hours:

  • Giansun (001400.SZ) traded flat 0 % and now trades at CNY 80.28. Giansun has a market capitalisation of CNY 6.1 bn.

  • Tellhow Sci-tech (600590.SS) traded flat 0 % and now trades at CNY 6.96. Current market capitalisation for Tellhow Sci-tech is CNY 6.1 bn. Tellhow Sci-tech has a current price to earnings ratio of 144.51.

  • Jin Tong Ling (300091.SZ) traded flat 0 % and now trades at CNY 2.13. Jin Tong Ling has a market capitalisation of CNY 6.1 bn.

  • Beijing Oriental Jicheng C (002819.SZ) traded flat 0 % and now trades at CNY 19.93. Beijing Oriental Jicheng C has a market capitalisation of CNY 6.2 bn.

  • Shenzhen Cotran New Materi (300731.SZ) traded flat 0 % and now trades at CNY 31.08. Current market capitalisation for Shenzhen Cotran New Materi is CNY 6.2 bn. Shenzhen Cotran New Materi has a current price to earnings ratio of 363.87. Shenzhen COTRAN New Materials has been highlighted in recent market discussions, primarily through institutional ownership data. In the latest quarterly filing, the company attracted attention from several institutional investors who disclosed holding its shares. These investors represent a mix of technology-focused funds, pension products, and asset management firms. The aggregate shareholding of these institutions accounts for a significant portion of the company’s equity, reflecting a growing institutional interest in its operations. Analysts note that this increase in institutional ownership may influence the company’s valuation dynamics, potentially stabilizing its share price. Market observers are watching how the company’s strategic initiatives and product developments might affect future investor confidence and trading activity.

About Jinxin Fertility

The Jinxin Fertility Group Ltd. is a health care company based in Chengdu, China, that specializes in providing assisted reproductive services. The company offers vitro fertilization services, embryo transfer services, management services, and other services. Additionally, Jinxin Fertility Group also provides ancillary medical services. Their website is www.jxr-fertility.com and they are listed on the Hong Kong Stock Exchange.